Synthesis and in vivo evaluation of cyclic diaminopropane BACE-1 inhibitors.
Thompson, L.A., Shi, J., Decicco, C.P., Tebben, A.J., Olson, R.E., Boy, K.M., Guernon, J.M., Good, A.C., Liauw, A., Zheng, C., Copeland, R.A., Combs, A.P., Trainor, G.L., Camac, D.M., Muckelbauer, J.K., Lentz, K.A., Grace, J.E., Burton, C.R., Toyn, J.H., Barten, D.M., Marcinkeviciene, J., Meredith, J.E., Albright, C.F., Macor, J.E.(2011) Bioorg Med Chem Lett 21: 6909-6915
- PubMed: 21974952 
- DOI: https://doi.org/10.1016/j.bmcl.2011.06.116
- Primary Citation of Related Structures:  
3SKF, 3SKG - PubMed Abstract: 
The synthesis, evaluation, and structure-activity relationships of a set of related constrained diaminopropane inhibitors of BACE-1 are described. The full in vivo profile of an optimized inhibitor in both normal and P-gp deficient mice is compared with data generated in normal rats.
Organizational Affiliation: 
Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA. lorin.thompson@bms.com